Literature DB >> 1448400

The menopause and hormone replacement therapy.

K T Khaw1.   

Abstract

Mesh：

Year:  1992        PMID： 1448400      PMCID： PMC2399546          DOI： 10.1136/pgmj.68.802.615

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  79 in total

1.  Re-evaluating the role of progestogen therapy after the menopause.

Authors:  B E Henderson; R K Ross; R A Lobo; M C Pike; T M Mack
Journal:  Fertil Steril       Date:  1988-05       Impact factor: 7.329

2.  Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community.

Authors:  M H Criqui; L Suarez; E Barrett-Connor; J McPhillips; D L Wingard; C Garland
Journal:  Am J Epidemiol       Date:  1988-09       Impact factor: 4.897

Review 3.  The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.

Authors:  T J Key; M C Pike
Journal:  Eur J Cancer Clin Oncol       Date:  1988-01

4.  Factors influencing the age at natural menopause.

Authors:  J L Stanford; P Hartge; L A Brinton; R N Hoover; R Brookmeyer
Journal:  J Chronic Dis       Date:  1987

5.  Postmenopausal estrogen, cancer and other considerations.

Authors:  E Barrett-Connor
Journal:  Women Health       Date:  1986 Fall-Winter

6.  Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark.

Authors:  M Ewertz
Journal:  Int J Cancer       Date:  1988-12-15       Impact factor: 7.396

7.  Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy.

Authors:  K Hunt; M Vessey; K McPherson; M Coleman
Journal:  Br J Obstet Gynaecol       Date:  1987-07

8.  Stroke incidence and risk factors for stroke in Copenhagen, Denmark.

Authors:  G Boysen; J Nyboe; M Appleyard; P S Sørensen; J Boas; F Somnier; G Jensen; P Schnohr
Journal:  Stroke       Date:  1988-11       Impact factor: 7.914

9.  Gynecologic consequences of long-term, unopposed estrogen replacement therapy.

Authors:  B Ettinger; I M Golditch; G Friedman
Journal:  Maturitas       Date:  1988-12       Impact factor: 4.342

10.  Estrogen replacement therapy and protection from acute myocardial infarction.

Authors:  B E Henderson; A Paganini-Hill; R K Ross
Journal:  Am J Obstet Gynecol       Date:  1988-08       Impact factor: 8.661
View more
  4 in total

Review 1.  Postmenopausal hormone replacement therapy, coronary heart disease and plasma lipoproteins.

Authors:  M Seed
Journal:  Drugs       Date:  1994       Impact factor: 9.546

2.  Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals.

Authors:  K T Khaw
Journal:  BMJ       Date:  1998-06-20

3.  Decreased non-esterified fatty acid suppression and features of the insulin resistance syndrome occur in a sub-group of individuals with normal glucose tolerance.

Authors:  C D Byrne; N J Wareham; N E Day; R McLeish; D R Williams; C N Hales
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

4.  Effects of Resonance Voice Therapy on Hormone-Related Vocal Disorders in Professional Singers: A Pilot Study.

Authors:  Laishyang Melody Ouyoung; Brenda Capobres Villegas; Changxing Liu; Guy Talmor; Uttam K Sinha
Journal:  Clin Med Insights Ear Nose Throat       Date:  2018-08-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.